Results 21 to 30 of about 89 (63)
, 2017 We describe herein a novel approach for the direct 11C-acetylation of amines. The carbonylative protocol is palladium-mediated, uses bis(cyclopentadienyldicarbonyliron) as the CO source, and [11C]methyl iodide or [11C]methyl iodide-D3 as a radioactive ...
Andersen +26 more
core +1 more source
Therapeutic Drug Monitoring (TDM)
, 2013 This chapter provides a review of the use of immunoassay in therapeutic drug monitoring. The immunoassay technology commonly used in this field is described (radioimmunoassay, enzyme-multiplied immunoassay technique, cloned enzyme donor immunoassay ...
Brandhorst +19 more
core +1 more source
, 2013 본 발명은 아세카이니드(Acecainide) 또는 이의 유도체인 프로카인아마이드(Procainamide), 또는 이의 약학적으로 허용가능한 염을 포함하는 근원세포(myoblast)의 분화 촉진용 조성물, 아세카이니드(Acecainide)또는 이의 유도체인 프로카인아마이드(Procainamide), 또는 이의 약학적으로 허용가능한 염을 체외 근원세포에 처리하는 단계를 포함하는 근원세포의 분화 촉진방법, 아세카이니드(Acecainide) 또는 이의 ...
권기선 +6 more
core
QSAR Model for Androgen Receptor Antagonism - Data from CHO Cell Reporter Gene Assays [PDF]
, 2012 Jensen, Gunde Egeskov +4 more
core +1 more source
Overview of therapeutic drug monitoring. [PDF]
Korean J Intern Med, 2009 Kang JS, Lee MH.
europepmc +1 more source
Novel high/low solubility classification methods for new molecular entities. [PDF]
Int J Pharm, 2016 Dave RA, Morris ME.
europepmc +1 more source
A quantitative threshold for high/low extent of urinary excretion of compounds in humans. [PDF]
Biopharm Drug Dispos, 2016 Dave RA, Morris ME.
europepmc +1 more source
Procainamide, but not N-acetylprocainamide, induces protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis. [PDF]
Chem Res Toxicol, 2008 Siraki AG +6 more
europepmc +1 more source
ABC of monitoring drug therapy. Measuring plasma drug concentrations. [PDF]
BMJ, 1992 Aronson JK, Hardman M.
europepmc +1 more source
Are there environmental forms of systemic autoimmune diseases? [PDF]
Environ Health Perspect, 1999 Hess EV.
europepmc +1 more source